Brief: theraclion's echopulse covered by french national health insurance for the treatment of breast fibroadenomas

Theraclion SA

12/07/2017 17:01

July 12 (Reuters) - THERACLION SA  ALTHER.PA : 
    * THERACLION'S ECHOPULSE COVERED BY FRENCH NATIONAL HEALTH 
INSURANCE FOR THE TREATMENT OF BREAST FIBROADENOMAS 
    * THIS FLAT-RATE COVERAGE IS FOR PERIOD OF 4 YEARS, 
INCLUDING 1 YEAR OF INCLUSION PERIOD, 1.5 YEARS OF FOLLOW-UP, 6 
MONTHS OF DATA ANALYSIS 
    * THIS FLAT-RATE COVERAGE INCLUDES ALSO 1 YEAR OF 
RE-EVALUATION PROCESSES BY THE FRENCH'S NATIONAL HEALTH 
AUTHORITY (HAS) 
    * AMOUNT OF PACKAGE INCLUDES PATIENT CARE AND ASSOCIATED 
HOSPITALIZATION EXPENSES AND IS THUS SET PER PATIENT AT EUR 
1,300 
    * SIX HUNDRED PATIENTS, AMONG WHICH 150 WITHIN THE STUDY, 
WILL BE ELIGIBLE FOR THIS COVERAGE 
    * TWELVE HIGHLY REPUTED CENTERS FROM ALL OVER FRANCE, BOTH 
FROM THE PRIVATE AND THE PUBLIC SECTOR, WILL PARTICIPATE IN THE 
STUDY 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw2gZfJca 
Further company coverage:  ALTHER.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))